Herbert K. Parker
Herbert K. Parker's purchase track record
How the stock did after each of Herbert K. Parker's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/28/2025 | TRS | $304K | +28.9% | +89.3% | +8.5% |
| 8/15/2024 | NVT | $497K | +10.8% | +1.2% | +10.3% |
| 5/1/2024 | TRS | $580K | -4.5% | +5.9% | +15.8% |
| 2/25/2022 | NVT | $12K | +5.4% | +0.5% | -7.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Apogee Enterprises Completes GroGlass Acquisition. Apogee Enterprises has completed the acquisition of GroGlass, a move intended to expand its Performance Surfaces segment. This strategic addition aims to broaden the company's product offerings within that specific business unit. The stock is currently trading near its 52-week low, with an average analyst target price of $44.00.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
nVent partners with AMD on cooling; RBC raises target. nVent Electric announced a collaboration with AMD to develop cooling solutions for the Helios Rackscale system. This partnership targets the growing data center infrastructure market. Separately, RBC Capital raised its price target to $208 while maintaining an Outperform rating. The company is scheduled to report third-quarter financial results on October 30.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Dauch names new CFO, faces lower price targets from Barclays and UBS. Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.
Transaction History
| TRS | ▼ Sell | Open Market | 15,000 | $675K | 6/30/2026 | View on chart |
| APOG | ▲ Buy | Grant | 2,741 | $115K | 6/24/2026 | View on chart |
| NVT | ▲ Buy | Grant | 976 | $0 | 5/15/2026 | View on chart |
| NVT | ▼ Sell | Tax Withholding | 602 | $102K | 5/15/2026 | View on chart |
| DCH | ▲ Buy | Grant | 29,773 | $0 | 4/30/2026 | View on chart |
| TRS | ▲ Buy | Grant | 2,853 | $0 | 3/14/2026 | View on chart |
| NVT | ▼ Sell | Open Market | 20,597 | $1.9M | 8/4/2025 | View on chart |
| APOG | ▲ Buy | Grant | 2,954 | $0 | 6/25/2025 | View on chart |
| NVT | ▲ Buy | Grant | 2,368 | $0 | 5/16/2025 | View on chart |
| NVT | ▼ Sell | Tax Withholding | 732 | $49K | 5/16/2025 | View on chart |
| DCH | ▲ Buy | Grant | 39,474 | $150K | 5/1/2025 | View on chart |
| TRS | ▲ Buy | Grant | 4,140 | $0 | 3/14/2025 | View on chart |
| TRS | ▲ Buy | Open Market | 14,612 | $304K | 2/28/2025 | View on chart |
| NVT | ▲ Buy | Open Market | 7,566 | $497K | 8/15/2024 | View on chart |
| APOG | ▲ Buy | Grant | 1,893 | $0 | 6/20/2024 | View on chart |
| NVT | ▲ Buy | Grant | 1,875 | $0 | 5/17/2024 | View on chart |
| NVT | ▼ Sell | Tax Withholding | 1,547 | $124K | 5/17/2024 | View on chart |
| TRS | ▲ Buy | Open Market | 6,000 | $158K | 5/8/2024 | View on chart |
| TRS | ▲ Buy | Open Market | 6,000 | $156K | 5/7/2024 | View on chart |
| TRS | ▲ Buy | Open Market | 6,100 | $162K | 5/6/2024 | View on chart |
| TRS | ▲ Buy | Open Market | 1,500 | $40K | 5/3/2024 | View on chart |
| TRS | ▲ Buy | Open Market | 1,500 | $39K | 5/2/2024 | View on chart |
| DCH | ▲ Buy | Grant | 20,492 | $150K | 5/2/2024 | View on chart |
| TRS | ▲ Buy | Open Market | 1,000 | $26K | 5/1/2024 | View on chart |
| APOG | ▼ Sell | Open Market | 15,728 | $949K | 4/23/2024 | View on chart |
| TRS | ▲ Buy | Grant | 4,068 | $0 | 3/14/2024 | View on chart |
| APOG | ▲ Buy | Grant | 2,409 | $0 | 6/21/2023 | View on chart |
| NVT | ▲ Buy | Grant | 3,515 | $0 | 5/12/2023 | View on chart |
| NVT | ▼ Sell | Tax Withholding | 1,602 | $66K | 5/12/2023 | View on chart |
| DCH | ▲ Buy | Grant | 20,030 | $0 | 5/4/2023 | View on chart |
| TRS | ▲ Buy | Grant | 3,445 | $0 | 3/11/2023 | View on chart |
| APOG | ▼ Sell | Open Market | 12,000 | $523K | 10/18/2022 | View on chart |
| APOG | ▲ Buy | Grant | 2,773 | $0 | 6/22/2022 | View on chart |
| NVT | ▲ Buy | Grant | 4,053 | $0 | 5/13/2022 | View on chart |
| NVT | ▼ Sell | Tax Withholding | 461 | $16K | 5/13/2022 | View on chart |
| DCH | ▲ Buy | Grant | 19,095 | $0 | 5/5/2022 | View on chart |
| TRS | ▲ Buy | Grant | 3,222 | $0 | 3/11/2022 | View on chart |
| NVT | ▲ Buy | Open Market | 361 | $12K | 2/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
TriMas Sets Q3 2026 Earnings Call Date
TriMas Corporation has announced the date for its third-quarter 2026 earnings conference call. This announcement provides a specific timeline for investors to receive the company's upcoming financial results. The stock is currently trading within its 52-week range, with analysts maintaining a target price of $45.00.
TriMas Sets Q3 2026 Earnings Call Date. TriMas Corporation has announced the date for its third-quarter 2026 earnings conference call. This announcement provides a specific timeline for investors to receive the company's upcoming financial results. The stock is currently trading within its 52-week range, with analysts maintaining a target price of $45.00.